Skip to content
The Nexus
DossierENTITY

penicillin G benzathine

Coverage of penicillin G benzathine in the Nexus archive.

Earliest in view: Jun 15 · 16:00 UTCMost recent: Jun 15 · 16:00 UTC
Co-mentioned in this coverage
Bicillin L-Atopic1Pfizerorganization1U.S. Food and Drug Administrationorganization1Lentocilintopic1King Pharmaceuticalsorganization1Elizabeth Finleyperson1National Coalition of STD Directorsorganization1Dr. Kelly Johnsonperson1
Recent coverage
  • HEALTHJun 15 · 16:00 UTCMISSOURI INDEPENDENT
    One US-made drug treats congenital syphilis, and the country is running short

    The U.S. faces a shortage of Bicillin L-A, the only first-line injectable penicillin for treating syphilis in pregnant women to prevent congenital syphilis. Pfizer's recall of the drug due to contamination risks has delayed supply until December 2027, forcing temporary reliance on imported Lentocilin. Health experts warn the shortage could worsen infection rates and disparities, as congenital syphilis causes severe, irreversible harm to infants.

penicillin G benzathine · Dossier · The Nexus